FDA Announces Pilot Project for Electronic Submission of Postmarketing Safety Reports for Vaccine Products

Summary

The FDA's Center for Biologics Evaluation and Research (CBER) is launching a pilot project to evaluate its electronic systems for receiving postmarketing safety reports involving vaccine products, with the goal of improving the efficiency of the Vaccine Adverse Event Reporting System (VAERS) and the Electronic Submissions Gateway (ESG).